NEW YORK, NY / ACCESS Newswire / August 1, 2025 / If you suffered a loss on your Vestis Corporation (NYSE:VSTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/vestis-corporation-lawsuit-submission-form?prid=159200&wire=1&utm_campaign=14 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

New Delhi, Aug. 01, 2025 (GLOBE NEWSWIRE) — Astute Connect, a leading expert network company trusted by over 500 global clients, has announced the release of its latest report titled “The Expert Network Market Sizing 2025.” The report provides a comprehensive analysis of the global expert network industry, highlighting significant growth and market trends. According

(NasdaqGM:NPCE), MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued the following statement in response to the Centers for Medicare & Medicaid Services (CMS) electing not to finalize its proposed reassignment of epilepsy with neurostimulator

(NASDAQ:ABEO), CLEVELAND, Aug. 01, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). On July 30, 2025, the Compensation Committee of Abeona's Board of Directors granted restricted stock

(TSX:GUD), MONTREAL, Aug. 01, 2025 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2025 financial results on Thursday, August 7, 2025 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties

(NasdaqGM:NTLA), CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on August 1, 2025, it awarded an inducement grant to five new employees under Intellia's 2024 Inducement Plan as a material inducement to employment. The inducement

(TSX:APS),(Pinksheets:APTOF),(PinkSheets:APTOF), SAN DIEGO and TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF; OTCQB: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), announced today that the Company's Board of

(NasdaqGM:NEXN), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that during July 2025 the Company repurchased 880,000 Ordinary Shares at an average price of $10.41. As of July 31, 2025,

Berkshire Hills Bancorp, Inc. (NYSE: BHLB) today announced that its Board of Directors has approved a quarterly cash dividend of $0.18 per common share to shareholders of record at the close of business on August 14, 2025, payable on August 21, 2025. https://mma.prnewswire.com/media/1626839/BHLB_Logo1.jpg About Berkshire Hills Bancorp Berkshire Hills Bancorp, Inc. (NYSE: BHLB) is the

Second Quarter Highlights* — Diluted EPS for the Quarter of $2.23, Up 68 percent, primarily due to the non-recurring 2024 impairment of intangible assets recognized in the Digital reporting unit — Adjusted Diluted EPS(1) for the Quarter of $2.46, Up 14 percent — Record Net Revenue for the Quarter of $587.3 million, Up 14 percent